000			02150cam a22005295i 4500
001			16183509
003			US-djbf
005			20210811112013.0
006			m d
007			cr cn|||||||||
008			100409s2010 dcua b 001 0 eng
010			_a2010015420
016	7		_a101528354 _2DNLM
020			_a0821383868 (alk. paper)
020			_a9780821383865 (alk. paper)
035			_a(The World Bank)ocn607465968
040			_aDNLM/DLC _cDLC _dYDX _dNLM _dCDX _dYDXCP _dDLC _beng _erda
042			_apcc
050	0	0	_aRA401.A1 _bS45 2010
060	1	0	_aQV 736 _bS462p 2010
082	0	0	_a362.17/82 _222
100	1		_aSeiter, Andreas. _917641
245	1	2	_aA practical approach to pharmaceutical policy / _cAndreas Seiter.
264		1	_aWashington, DC : _bWorld Bank, _c[2010]
264		4	_ccopyright 2010.
300			_axxi, 215 pages : _billustrations ; _c23 cm.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_adata file _2rda
380			_aBibliography
490	1		_aDirections in development
504			_aIncludes bibliographical references and index.
505	0		_aPharmaceutical policy goals -- Introducing the stakeholders -- Patterns of dysfunction -- Key elements of a successful pharmaceutical policy -- Policy packages to achieve strategic long-term goals -- Factors influencing policy implementation -- Pharmaceutical policy illustrated in country examples -- Pharmaceutical policy outlook.
588			_aDescription based on print version record.
650	1	2	_aDrug Industry _xorganization & administration. _917642
650	2	2	_aDeveloped Countries. _917643
650	2	2	_aGovernment Regulation. _917644
650	2	2	_aHealth Plan Implementation. _917645
650	2	2	_aHealth Policy _xeconomics. _917646
650		0	_aPharmaceutical policy. _917647
710	2		_aWorld Bank. _917648
776	0	8	_aPrint Version: _z9780821383865
830		0	_aDirections in development (Washington, D.C.) _917649
830		0	_aWorld Bank e-Library. _917650
856	4	0	_uhttp://elibrary.worldbank.org/doi/book/10.1596/978-0-8213-8386-5
999			_c4163 _d4163